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Fo r the pas t decade, investigators have been on the trail of mes-
ench ym al cells in th e epidermi s, as kin g whether these cells have 
an immullological function and , if so, w hat it is. N ow, Georg 
Stingl reported at the Annual Meeting of The Society for Inves-
tigative Derm ato logy, Inc., at least some of the answers are in . 
In his M ontagna lecture, on May 2, 1986, Stingl noted that not 
only are the immunologica l functions of these cell s becoming 
increasi ng ly clear, but their roles in pathologic processes are be-
coming apparent. In particular, Stin g l provided new evidence that 
Langerh ans cells in the ep iderm is may well be a reservo ir for the 
autoimmune defi ciency synd rome (AIDS) virus. 
The story begins in 1976 when In ga Silberberg and RudolfBaer 
at New Yo rk University found the first potential link between 
immune responsiveness and Langerhans cells. Using electron mi-
croscopy, they noticed that Langerhans cells are next to lym-
phocytes in the sk in of patients w ith contact hypersensit ivity and 
that these Langerh ans cell s are damaged. T his suggested that Lan-
gerhans cell s mi ght somehow be in volved in conta ct hypersen-
sitivity . 
T hen, in 1977, Stingl, w ho was then working with Stephen 
Katz and his co lleagues at the N ationa l Institutes of Hea lth , re-
ported that Langerhans cells in human skin express certain anti-
, gens on their sur[1ces and these antigens are typical of immune 
sys te m cells. In particul ar, the NIH resea rchers found that Lan-
gerhans cells resemble monocytes o r macrophages more than T 
• and B cells. But, says Stin gl, " Langerh ans cells are very poor 
phagocytes . " 
AboLit a yea r later , Stingl, Katz, and their associates got a partial 
answer. Langerhans cell s, they found, may be ca pable of stim-
ulati ng T cells. When they added an tigen-bea rin g Langerhans cells 
to T cells in vitro , the T cells proliferated. But their Langerh ans 
, cells preparations were not pure-they contained keratinocytes, 
among other cells. At the time, says Stin g l, " Keratinocy tes were 
cons idered innocent bystanders." But it turns out that " ... 
kerat inocytes turn o ut a plethora of immune regulatory sub-
stances . One of the greatest hazards in science is oversimplifi-
cation," Stingl remarks. 
Another difficulty w ith concludin g from these initi al experi-
ments that Langerhans cell s are ca pable of stimul ating T cell s is 
that the researchers did not know whether Langerhans cells co uld 
stimulate primary resting T cells. Their work showed onl y that 
Langerhans cells can stimulate sensitized T cell s. O nl y if the Lan-
gerhans cells were indeed capable of initiatin g a primary immune 
response could they ho ld th em respons ible for inducing the re-
actions in whi ch they suspected the III of playing a cri tica l ro le-
contact hypersensit ivity and skin allograft rea ctions. But it was 
not until several researchers performed further careful in vi tro 
experiments that it beca me clear that Langerhans cell s can, in fact, 
stimulate primary res tin g T cells. In ves tigators Paul Bergstresser 
and Wayne Strei lein at the Hea lth Science Center, Da ll as, Texas, 
were the first to demonstrate that these in vitro data were of 
actual in vivo signi fica nce. They provided ev idence that Langer-
hans cells arc the principal sensitizing cells in the induction of 
contact hypersensitivity . 
Bu t there was still the question of w hether it was Langerhans 
cells or other cells present along with them th at were prod ucing 
these effects. "We had to purify the Langerhans cells to see if they 
alone were res ponsible for the T cell response," Stingl says. " It 
was a Herculean tas k. H.esear~l,l:,rs curs,,;d the cells il~, E nglish, 
French, German, and Japanese. N ow, says Stl11gl, we must 
confess th at we have come very close but that we have not re-
producibly achieved this goa l. In general, however, we find that 
the better the purification, the better the T cell sensitization. " 
N ow it ·is es tablished that Langerhans cells take up antigens , 
process them , and present them to T cells. Unlike B cells, T cells 
can on ly recognize antigens when they are presen ted by another 
cell bearin g "self" antigens. 
Next ca me the questions of w here Langerhans cells come from, 
w here they are going, and to w hich cell lineage th ey belong . 
Langerh ans cells as wel l as macrop hages and dendritic cells are 
derived from and are continu all y replaced by precursors origi-
natin g in the bone marrow. "We got the impressio n that Lan-
gerh ans cells are somewhere between mononuclear macrophages 
and dendritic cells," Sting l remarks . "The cell surface anti gen 
distribution co uld either indica te that Langerhans cells are a tran-
si ti onal phase or a final end product of a unique different iation 
pathway of bone marrow-derived cells." 
One hint of w hat might be going o n comes from observing 
Langerhans cells in culture. "Langerhans cells not only survive 
in culture but undergo profound phenotypic changes," says Stingl. 
T hey lose Fc-lgG receptors , ATPase activity, and Brrbeck g ran-
ules, but in crease their la antigens. In short, they become more 
and more like dendritic cells. Moreover, there arc ind ica tions that 
the same changes mig ht occur with Langerhans cells in vivo. 
There are veiled cells in the afferent lymphatics and interd ig itated 
cells in the paracortical T -dependent areas of the lymph nodes 
that are indistin gu ishable fr0111 dendritic cells . 
Veiled cells increase in number w hen Langerhans cells in the 
skin are exposed to antigens. Hence, one model is that Langerhans 
cells beco me vei led cells wh ich beco me interdigitating cells which 
then become dendritic cells. But this model has a weakness, Sting l 
points out. It is known that dendritic cells can be grown directly 
from bone marrow cell s. So, despite the attractiveness of this 
model, " We ca nn ot excl ude the possibility that Langerhans cells 
arc the final product of the monocyte differentiation path way and 
that there is a separate pathway for veiled cells and dendriti c cells," 
Stin g l says. 
Future goals of research on Langerhans cells are to determine 
the d ifferen tiation pathway, the traffic, and the ultimate fate of 
these cells. Although it may well be that the major function of 
Langerhans cells is to activate specialized effects of helper T cells, 
Stingl warns that, "we don't want the concept of Langer hans cells 
to be too narrow. I strongly believe that these cells have a lot to 
do at home in the epidermis. T he o ld concepts that Langerhans 
cells have a scavenger function and that they may inAuence growth 
and differentiatio n of other epiderma l cell s sho ul d be carefull y 
in vestiga ted. Finally, let's not forget the quest fo r the holy grail 
of Langerhans cell resea rch-Langerhans cell tumorogenesis." 
In the meantime, Stingl and his colleagues E rw in Tschachler, 
Veronika G roh, Klaus Konrad, and Klaus Wolff of the University 
of Vienna, along with Mica Popovic and Dean Mann of the 
N ationa l Ca ncer In stitute and Bij an Safa i from Memorial Sloan 
Ketterin g Cancer Center recentl y obta ined evidence linking Lan-
gerhans cell s to AIDS. They noted that Langerhans cells express 
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T4 anti gens, w hi ch are bin din g sites for th e AIDS virus. So, they 
asked, mi g ht Lange rh ans cells be a preferenti al target fo r the AIDS 
viru s? T hey o btained sk in biopsies fro m 40 indi viduals with AID S 
o r AIDS-Helated-Complex and simil ar bi o psies from 84 sero-
negative persons w ho served as controls. In approximate ly 17% 
o f all biopsies from the AIDS o r A RC patients, th e Langerhans 
el ls were the on ly ep idlTma l cel ls to react with monoclona l an-
tibod ies aga inst HTL V - III. M o reover, there were viral pa rticles 
indi sti ngui shable frolll 1-ITLV-1I1 associa ted w ith the Lan gerhans 
cells in one of these biopsies . O nl y one of the contro ls had Lan-
gerh ans cell s that reacted with the I-1TLV-11I antibody and this 
was a patient w ith classica l Kapos i's sa rco m a. Since the skin is 
the largest o rga n of the bod y and sin ce the biopsies were onl y 
very sma ll sa illpl es, it rema ins possible that Ill o re than 17% of 
the Langerha ns cell s fro lll th ese AIDS and AR C patients conta in 
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the virus. "We be lieve these data strong ly suggest that Langerhans 
cell s are a target and a potential reservo ir for the AIDS virus, '~ 
Stin g l says. 
A I DS virus is onl y rare ly fou nd in circul ati ng T cells of patients , 
pro babl y beca use it ki lls these cells so quick ly that either they are 
destroyed o r are present and uninfected. So the finding of the 
virus in Langerhans cells is potentiall y very impo rtant. It may 
have adverse co nsequ ences for the immuno logi.ca l functions of 
this ce ll syste m , and m ay thus co ntribute to both the acq uisition 
of immunodefi ciency and the infectio us and neo plas tic conse-
quences of A IDS. 
T he pas t decade of intensive stud y of Lange rhans cells has been 
enorm o usly fru itfu l. But, as the AIDS work indica tes, it may 
well be that the m ost interestin g findin gs are yet to co m e. 
